6:34 PM
 | 
Oct 31, 2012
 |  BC Extra  |  Company News

Novartis to build biologics facility in Singapore

Novartis AG (NYSE:NVS; SIX:NOVN) plans to build a new facility in the Tuas area of Singapore to support clinical...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >